KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Diversified Healthcare Trust (DHC) EBITDA (2016 - 2025)

Historic EBITDA for Diversified Healthcare Trust (DHC) over the last 17 years, with Q3 2025 value amounting to -$124.8 million.

  • Diversified Healthcare Trust's EBITDA fell 13655.34% to -$124.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$279.7 million, marking a year-over-year decrease of 38074.07%. This contributed to the annual value of -$159.7 million for FY2024, which is 4457.18% down from last year.
  • Diversified Healthcare Trust's EBITDA amounted to -$124.8 million in Q3 2025, which was down 13655.34% from -$51.4 million recorded in Q2 2025.
  • In the past 5 years, Diversified Healthcare Trust's EBITDA registered a high of $499.1 million during Q4 2021, and its lowest value of -$124.8 million during Q3 2025.
  • In the last 5 years, Diversified Healthcare Trust's EBITDA had a median value of $40.5 million in 2023 and averaged $49.9 million.
  • As far as peak fluctuations go, Diversified Healthcare Trust's EBITDA skyrocketed by 391377.6% in 2023, and later tumbled by 20644.41% in 2024.
  • Quarter analysis of 5 years shows Diversified Healthcare Trust's EBITDA stood at $499.1 million in 2021, then plummeted by 90.01% to $49.9 million in 2022, then increased by 5.49% to $52.6 million in 2023, then plummeted by 193.06% to -$49.0 million in 2024, then tumbled by 154.86% to -$124.8 million in 2025.
  • Its EBITDA stands at -$124.8 million for Q3 2025, versus -$51.4 million for Q2 2025 and -$54.7 million for Q1 2025.